What is CAR Cell?
To Better understand the CAR T cells, we might first answer this question that "What is CAR cell?"
What is CAR cell therapy?
Chimeric Antigen Receptor (CAR) cell therapy is a groundbreaking approach in cancer treatment that involves genetically modifying a patient’s immune cells to better recognize and attack cancer cells. In this therapy, a patient's T cells (a type of white blood cell) are collected and engineered to express specific receptors on their surface called CARs. These receptors are designed to target proteins found on the surface of cancer cells. Once infused back into the patient, these CAR-modified cells can identify and destroy cancer cells more effectively, offering hope for treating cancers that are resistant to traditional therapies.
What is CAR T cell?
CAR T cell therapy is the most well-known form of CAR cell therapy. In this method, the T cells are engineered to express a CAR that specifically targets antigens on tumor cells. CAR T cells have shown remarkable success in treating certain types of blood cancers, like leukemia and lymphoma, by honing in on cancerous cells while sparing most healthy cells. This form of immunotherapy has revolutionized the landscape of cancer treatment, offering personalized and highly effective solutions, though challenges such as managing side effects and ensuring long-term effectiveness still remain.
Process of iPSC derived CAR T cell production